SCHEMBL4789345

SCHEMBL4789345

Cc1ccc(Nc2cc(OC3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnc2[nH]ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 5/20 0.58
ABL1 P00519 2/20 0.56
BRAF P15056 9/20 0.54
EGFR P00533 5/20 0.54
KDR P35968 3/20 0.49
LCK P06239 3/20 0.49
SRC P12931 2/20 0.49
INSR P06213 1/20 0.49
LYN P07948 1/20 0.49
HCK P08631 1/20 0.49
MAPK14 Q16539 2/20 0.46
RAF1 P04049 1/20 0.46
ARAF P10398 1/20 0.46
TYK2 P29597 1/20 0.42
SYK P43405 1/20 0.42
JAK3 P52333 1/20 0.42
BTK Q06187 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4789348 0.92 CSF1R (0.68) CSF1RABL1BRAFEGFRKDR
SCHEMBL4788124 0.84 ABL1 (0.59) CSF1RABL1BRAFEGFRLYN
SCHEMBL4789584 0.82 CSF1R (0.57) CSF1RABL1BRAFEGFRLYN
SCHEMBL4787030 0.80 BRAF (0.61) CSF1RABL1BRAFEGFRLCK
SCHEMBL4789367 0.79 ABL1 (0.56) CSF1RABL1BRAFEGFRLYN
SCHEMBL4789207 0.78 ABL1 (0.55) CSF1RABL1BRAFEGFRKDR
SCHEMBL4788636 0.78 EPHB2 (0.59) CSF1RABL1BRAFKDRLCK
SCHEMBL4788129 0.78 BRAF (0.67) CSF1RABL1BRAFEGFRKDR
SCHEMBL4789587 0.76 CSF1R (0.68) CSF1RABL1BRAFEGFRLYN
SCHEMBL4788536 0.73 LCK (0.46) CSF1RBRAFKDRLCKMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008144253-A1 PROTEIN KINASE INHIBITORS AND METHODS FOR USING THEREOF IRM LLC (BM) 2008-11-27 WO claimed
WO-2008144253-A1 PROTEIN KINASE INHIBITORS AND METHODS FOR USING THEREOF IRM LLC (BM) 2008-11-27 WO disclosed